Global Fund Health Impact Evaluation 2008

Ethiopia, 2008

Reference ID

ETH_2008_EGFHIE_v01_M

Producer(s)

Ethiopian Health and Nutrition Research Center (EHNRI), , ,

Metadata

DDI/XML JSON

Created on

Sep 29, 2011

Last modified

Mar 29, 2019

Page views

57846

Downloads

1591

Data files
R0
R1
R2A
R2A2
R2A3
R2B
R3
R4
R5
R6A
R6B
R6C
R6D
R6E
R7A
R7B
R7C
R8A
R8B
R8C
R8D
R8E

Data file: R6B

Malaria Medicines

Variables:	12

Variables

QCOUNTRY

QID

Q603_01

Malaria Medicine: Coartem and artemisinin combination therapy (ACT) (Artemeter + Lumefantrine)

Q603_02

Malaria Medicine: Artemisinin (oral) - not as combination therapy

Q603_03

Malaria Medicine: Fansidar (SP, sulfadoxine + pyrimethamine) 500mg+25mg

Q603_04

Malaria Medicine: Quinine (oral or injectable)

Q603_05

Malaria Medicine: Other antimalarial drugs (oral or injectable)

Q604_01

Malaria Medicine available in last 3 months: Coartem and artemisinin combination therapy (ACT) (Artemeter + Lumefantrine)

Q604_02

Malaria Medicine available in last 3 months: Artemisinin (oral) - not as combination therapy

Q604_03

Malaria Medicine available in last 3 months: Fansidar (SP, sulfadoxine + pyrimethamine) 500mg+25mg

Q604_04

Malaria Medicine available in last 3 months: Quinine (oral or injectable)

Q604_05

Malaria Medicine available in last 3 months: Other antimalarial drugs (oral or injectable)

Total: 12

Back to Catalog